The effect of active immunization on varicella-related hospitalizations in Israel

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The purpose of this study is to report on the impact of introduction of the varicella vaccine "Varilix" on hospitalizations due to varicella, following licensure in Israel in June, 2000. Data on children hospitalized throughout Israel with the diagnosis of varicella were collected from 1998 until 2003. The national rate of varicella-related hospitalizations decreased during the period 2001-2002. However in 2003 an increase in hospitalization occurred. Based on an assumption that at least 22,000 vaccinations per year were administered, we estimate that there is a greater than 60% reduction in the risk for hospitalization in the immunized population (RR = 0.32; 0.10-1.00). In summary, no national trend in reduction of hospitalization has yet been observed, but a significant reduction in hospitalization is apparent for vaccinated children. © 2009 Landes Bioscience.

Cite

CITATION STYLE

APA

Lerner-Geva, L., Hirsh-Yechezkel, G., Novikov, I., Farkash, H., Boyko, V., Spirer, Z., & Passwell, J. H. (2009). The effect of active immunization on varicella-related hospitalizations in Israel. Human Vaccines, 5(3), 136–140. https://doi.org/10.4161/hv.5.3.6811

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free